ARTA
NYMX

A.R.T. Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

A.R.T. Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-18,968
Closed -$28K – 1806
2019
Q2 		$28K Buy
+18,968
New +$33.2K ﹤0.01% 1281
2016
Q1 		– Sell
-23,511
Closed -$77K – 1726
2015
Q4 		$77K Buy
+23,511
New +$78.9K ﹤0.01% 1352

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

A.R.T. Advisors's NYMX Position: Q3 2019 in Review

A.R.T. Advisors sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2019, closing a stake of 18,968 shares — an estimated $28K sold.

A.R.T. Advisors first reported a position in NYMX in Q4 2015 and held it in 2 quarters. The position peaked at $77K in Q4 2015. 38 funds tracked by Wall St. Rank hold NYMX as of Q3 2019.

  • A.R.T. Advisors reported no remaining Nymox Pharmaceutical Corp position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 18,968 Nymox Pharmaceutical Corp shares in Q3 2019, an estimated $28K.
  • A.R.T. Advisors first reported a position in Nymox Pharmaceutical Corp in Q4 2015 and held it in 2 quarters.
  • A.R.T. Advisors's Nymox Pharmaceutical Corp position peaked at $77K in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.